CSL secured rights to MSD's vaccines in Australia and New Zealand as part of an agreement negotiated in the 1990s under which the US company gained global development and commercialisation rights to the investigative candidate that became GARDASIL. …
MSD to bring vaccine distribution back in-house after 40-year partnership
December 1, 2025 Latest NewsBioPharma
Latest Video
Georgia Forrest
New Stories
-
New treatment listed on PBS, offering twice-yearly dosing for Australians with relapsing MS
January 9, 2026 - - Latest News -
The value of looking back and the importance of seeing the 'smoke signals' on reform
January 8, 2026 - - Latest News -
Vaxxas appoints former global vaccines leader to head global commercialisation push
January 8, 2026 - - Australian Biotech -
Reform was justified because a committee prioritising clinical considerations was 'culturally' problematic
January 4, 2026 - - Latest News -
AdAlta and SHcell launch cancer collaboration to progress breakthrough CAR-T therapy
January 2, 2026 - - Australian Biotech -
Cabinet documents from the year that led to transformational changes
January 1, 2026 - - Latest News -
US pricing push gets real with Australia included in comparison list
December 22, 2025 - - Latest News